Steno Diabetes Center Copenhagen: all 113 studies
Page 2 of 2. Open to participants first (22), then studies with results posted, then the rest; newest registration first within each.
- Study of 24 Hour Blood Pressure and the Association to Complications to Type 1 DiabetesCompletedNCT01171248
- A Crossover Study With Hexalacton in Patients With Type 1 Diabetes and MicroalbuminuriaStatus unknownNCT00843388Phase 4
- Anti-Interleukin-1 in Diabetes ActionCompletedNCT00711503Phase 2/3
- The Copenhagen Insulin and Metformin Therapy TrialCompletedNCT00657943Phase 4
- Autoregulation of Glomerular Filtration Rate in Patients With Type 1 Diabetes During Spironolactone TherapyCompletedNCT00335413Phase 4
- Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent MicroalbuminuriaCompletedNCT00320879Phase 4
- Spironolactone in Diabetic NephropathyCompletedNCT00317954Phase 4
- Irbesartan in Type 2 DiabetesCompletedNCT00317915Phase 3
- Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic NephropathyCompletedNCT00311870Phase 4
- Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney DiseaseCompletedNCT00118976Not applicable
- Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-DiabetesCompletedNCT00118963Phase 4
- Effect of Metformin Versus Repaglinide Treatment in Non-Obese Type 2 Diabetic Patients Uncontrolled by DietCompletedNCT00118950Phase 4
- Effect of Metformin in Patients With Type-1 Diabetes With Inadequate Glycaemic Control by Insulin and DietCompletedNCT00118937Phase 4